American Endowment Foundation 13D and 13G filings for Cyclerion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 1:25 pm Purchase | 2024-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN | American Endowment Foundation | 133,026 4.910% | 133,026 (New Position) | Filing |